Peter Jiang

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Duration of First Off-Treatment Interval Is Prognostic for Time to Castration Resistance and Death in Men With Biochemical Relapse of Prostate Cancer Treated on a Prospective Trial of Intermittent Androgen Deprivation

Evan Y. Yu, Roman Gulati, Donatello Telesca et al. · Journal of Clinical Oncology · 2010 · 66 citations · Full text

Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells

H. Joachim Deeg, Peter Jiang, Leona Holmberg et al. · Leukemia Research · 2004 · 61 citations

Bone Marrow Failure, Autoimmune Disease, Malignant Blood Disorder +10

Recycled HDPE reinforced with sol–gel silica modified wood sawdust

Witold Brostow, Tea Datashvili, Peter Jiang et al. · European Polymer Journal · 2016 · 56 citations

Materials Science, Wood Sawdust, Engineering +3